Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis-Reference-Cited by-同舟云学术

Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis

Published:2020-03-11 Issue:7 Volume:61 Page:1592-1600
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bubik Rachel J.¹^ORCID,Barth Dylan M.²,Hook Christopher³,Wolf Robert C.¹,Muth Jessica M.¹,Mara Kristin⁴,Patnaik Mrinal S.³^ORCID,Pruthi Rajiv K.³,Marshall Ariela L.³⁵^ORCID,Litzow Mark R.³^ORCID,Elliott Michelle A.³,Hogan William J.³^ORCID,Shah Mithun V.³,Begna Kebede H.³,Alkhateeb Hassan³,Pardanani Animesh³,Ashrani Aneel A.³,Call Timothy G.³,Rivera Candido E.³,Camoriano John K.³,Go Ronald S.³,Wolanskyj-Spinner Alexandra P.³,Parikh Sameer A.³

Affiliation:

1. Department of Pharmacy, Mayo Clinic, Rochester, MN, USA;

2. Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL, USA;

3. Division of Hematology, Mayo Clinic, Rochester, MN, USA;

4. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA;

5. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1737684